Cargando…
Prioritizing symptom management in the treatment of chronic heart failure
Chronic heart failure (CHF) is a chronic, progressive disease that has detrimental consequences on a patient's quality of life (QoL). In part due to requirements for market access and licensing, the assessment of current and future treatments focuses on reducing mortality and hospitalizations....
Autores principales: | Koshy, Aaron O., Gallivan, Elisha R., McGinlay, Melanie, Straw, Sam, Drozd, Michael, Toms, Anet G., Gierula, John, Cubbon, Richard M., Kearney, Mark T., Witte, Klaus K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524132/ https://www.ncbi.nlm.nih.gov/pubmed/32757363 http://dx.doi.org/10.1002/ehf2.12875 |
Ejemplares similares
-
Suboptimal Dosing of β-Blockers in Chronic Heart Failure: A Missed Opportunity?
por: McGinlay, Melanie, et al.
Publicado: (2022) -
Effect of disease‐modifying agents and their association with mortality in multi‐morbid patients with heart failure with reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2020) -
Four pillars of heart failure: contemporary pharmacological therapy for heart failure with reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2021) -
Guideline-directed medical therapy is similarly effective in heart failure with mildly reduced ejection fraction
por: Straw, Sam, et al.
Publicado: (2022) -
Association of heart failure and its comorbidities with loss of life expectancy
por: Drozd, Michael, et al.
Publicado: (2021)